1887

Abstract

Introduction

Cases of infections are being increasingly recognized in geographical regions that were traditionally regarded as non-endemic. Here, we describe a case of meningoencephalitis in an immunocompetent Filipino male diagnosed in Kuwait.

Case presentation:

A 34-year-old healthy Filipino male presented with a history of progressive generalized headache, nausea and repeated episodes of vomiting. The patient had continuously lived and worked in Kuwait for three consecutive years before developing the disease. The diagnosis of meningoencephalitis was established by demonstrating capsulated budding yeast cells in cerebrospinal fluid, isolating in culture and detecting cryptococcal polysaccharide antigen in serum and cerebrospinal fluid specimens. Molecular characterization of the isolate confirmed its identity as , genotype AFLP6/VGII. The isolate showed reduced susceptibility to fluconazole and was treated suboptimally until flucytosine became available.

Conclusions:

A case of meningoencephalitis in a healthy Filipino male, who apparently acquired the infection in his native country, is described. The infection remained dormant for several years before becoming clinically apparent. To the best of our knowledge, this is the first report of meningitis diagnosed in Kuwait.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.000058
2015-06-01
2020-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/2/3/jmmcr000058.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.000058&mimeType=html&fmt=ahah

References

  1. Bovers M., Hagen F., Boekhout T.. 2008; Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol25:S4–S12 [CrossRef]
    [Google Scholar]
  2. Byrnes E. J. III, Bartlett K. H., Perfect J. R., Heitman J.. 2011; Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect13:895–907 [CrossRef]
    [Google Scholar]
  3. Castrodale L. J., Gerlach R. F., Preziosi D. E., Frederickson P., Lockhart S. R.. 2013; Prolonged incubation period for Cryptococcus gattii infection in cat, Alaska, USA. Emerg Infect Dis19:1034–1035 [CrossRef]
    [Google Scholar]
  4. Chen S. C., Slavin M. A., Heath C. H., Playford E. G., Byth K., Marriott D., Kidd S. E., Bak N., Currie B., other authors. 2012; Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis55:789–798 [CrossRef]
    [Google Scholar]
  5. Chen S. C., Korman T. M., Slavin M. A., Marriott D., Byth K., Bak N., Currie B. J., Hajkowicz K., Heath C. H., other authors. 2013; Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis57:543–551 [CrossRef]
    [Google Scholar]
  6. Chowdhary A., Randhawa H. S., Boekhout T., Hagen F., Klaassen C. H., Meis J. F.. 2012; Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis18:172–174 [CrossRef]
    [Google Scholar]
  7. Datta K., Bartlett K. H., Baer R., Byrnes E., Galanis E., Heitman J., Hoang L., Leslie M. J., MacDougall L., other authors. 2009; Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis15:1185–1191 [CrossRef]
    [Google Scholar]
  8. Dromer F., Ronin O., Dupont B.. 1992; Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J Med Vet Mycol30:395–397 [CrossRef]
    [Google Scholar]
  9. Espinel-Ingroff A., Aller A. I., Canton E., Castañón-Olivares L. R., Chowdhary A., Cordoba S., Cuenca-Estrella M., Fothergill A., Fuller J., other authors. 2012; Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother56:5898–5906 [CrossRef]
    [Google Scholar]
  10. Garcia-Hermoso D., Janbon G., Dromer F.. 1999; Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol37:3204–3209
    [Google Scholar]
  11. Georgi A., Schneemann M., Tintelnot K., Calligaris-Maibach R. C., Meyer S., Weber R., Bosshard P. P.. 2009; Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection37:370–373 [CrossRef]
    [Google Scholar]
  12. Hagen F., Illnait-Zaragozi M. T., Bartlett K. H., Swinne D., Geertsen E., Klaassen C. H., Boekhout T., Meis J. F.. 2010; In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother54:5139–5145 [CrossRef]
    [Google Scholar]
  13. Hagen F., Colom M. F., Swinne D., Tintelnot K., Iatta R., Montagna M. T., Torres-Rodriguez J. M., Cogliati M., Velegraki A., other authors. 2012; Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis18:1618–1624 [CrossRef]
    [Google Scholar]
  14. Hagen F., Ceresini P. C., Polacheck I., Ma H., van Nieuwerburgh F., Gabaldón T., Kagan S., Pursall E. R., Hoogveld H. L., other authors. 2013; Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One8:e71148 [CrossRef]
    [Google Scholar]
  15. Hagen F., Chowdhary A., Prakash A., Yntema J. B., Meis J. F.. 2014; Molecular characterization of Cryptococcus gattii genotype AFLP6/VGII isolated from woody debris of divi-divi (Caesalpinia coriaria), Bonaire, Dutch Caribbean. Rev Iberoam Micol31:193–196 [CrossRef]
    [Google Scholar]
  16. Harris J. R., Lockhart S. R., Sondermeyer G., Vugia D. J., Crist M. B., D'Angelo M. T., Sellers B., Franco-Paredes C., Makvandi M., other authors. 2013; Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis19:1620–1626
    [Google Scholar]
  17. Illnait-Zaragozí M. T., Hagen F., Fernández-Andreu C. M., Martínez-Machín G. F., Polo-Leal J. L., Boekhout T., Klaassen C. H., Meis J. F.. 2011; Reactivation of a Cryptococcus gattii infection in a cheetah (Acinonyx jubatus) held in the National Zoo, Havana, Cuba. Mycoses54:e889–e892 [CrossRef]
    [Google Scholar]
  18. Illnait-Zaragozí M. T., Ortega-Gonzalez L. M., Hagen F., Martínez-Machin G. F., Meis J. F.. 2013; Fatal Cryptococcus gattii genotype AFLP5 infection in an immunocompetent Cuban patient. Med Mycol Case Rep2:48–51 [CrossRef]
    [Google Scholar]
  19. Johannson K. A., Huston S. M., Mody C. H., Davidson W.. 2012; Cryptococcus gattii pneumonia. CMAJ184:1387–1390 [CrossRef]
    [Google Scholar]
  20. Khan Z. U., Randhawa H. S., Kowshik T., Chowdhary A., Chandy R.. 2007; Antifungal susceptibility of Cryptococcus neoformansCryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosaSyzygium cumini trees in north-western India. J Antimicrob Chemother60:312–316 [CrossRef]
    [Google Scholar]
  21. Khayhan K., Hagen F., Pan W., Simwami S., Fisher M. C., Wahyuningsih R., Chakrabarti A., Chowdhary A., Ikeda R., other authors. 2013; Geographically structured populations of Cryptococcus neoformans variety grubii in Asia correlate with HIV status and show a clonal population structure. PLoS One8:e72222 [CrossRef]
    [Google Scholar]
  22. Kidd S. E., Hagen F., Tscharke R. L., Huynh M., Bartlett K. H., Fyfe M., Macdougall L., Boekhout T., Kwon-Chung K. J., Meyer W.. 2004; A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia Canada). Proc Natl Acad Sci U S A101:17258–17263 [CrossRef]
    [Google Scholar]
  23. Lindberg J., Hagen F., Laursen A., Stenderup J., Boekhout T.. 2007; Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg Infect Dis13:178–179 [CrossRef]
    [Google Scholar]
  24. Lockhart S. R., Iqbal N., Bolden C. B., DeBess E. E., Marsden-Haug N., Worhle R., Thakur R., Harris J. R.. Cryptococcus gattii PNW Public Health Working Group (2012) Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis73:144–148 [CrossRef]
    [Google Scholar]
  25. Loyse A., Dromer F., Day J., Lortholary O., Harrison T. S.. 2013; Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother68:2435–2444 [CrossRef]
    [Google Scholar]
  26. Ma H., Hagen F., Stekel D. J., Johnston S. A., Sionov E., Falk R., Polacheck I., Boekhout T., May R. C.. 2009; The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci U S A106:12980–12985 [CrossRef]
    [Google Scholar]
  27. MacDougall L., Fyfe M.. 2006; Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol44:1851–1852 [CrossRef]
    [Google Scholar]
  28. Meyer W., Aanensen D. M., Boekhout T., Cogliati M., Diaz M. R., Esposto M. C., Fisher M., Gilgado F., Hagen F., other authors. 2009; Consensus multi-locus sequence typing scheme for Cryptococcus neoformansCryptococcus gattii. Med Mycol47:561–570 [CrossRef]
    [Google Scholar]
  29. Mitchell D. H., Sorrell T. C., Allworth A. M., Heath C. H., McGregor A. R., Papanaoum K., Richards M. J., Gottlieb T.. 1995; Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis20:611–616 [CrossRef]
    [Google Scholar]
  30. Ngamskulrungroj P., Serena C., Gilgado F., Malik R., Meyer W.. 2011; Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. Clin Microbiol Infect17:251–258 [CrossRef]
    [Google Scholar]
  31. Park B. J., Lockhart S. R., Brandt M. E., Chiller T. M.. 2011; Public health importance of cryptococcal disease: epidemiology, burden and control. In Cryptococcus: From Human Pathogen to Model Yeast pp585–593Edited by Heitman J., Kozel T. R., Kwon-Chung K. J., Perfect J. R., Casadevall A.. Washington, DC: American Society for Microbiology; [CrossRef]
    [Google Scholar]
  32. Perfect J. R., Dismukes W. E., Dromer F., Goldman D. L., Graybill J. R., Hamill R. J., Harrison T. S., Larsen R. A., Lortholary O., other authors. 2010; Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis50:291–322 [CrossRef]
    [Google Scholar]
  33. Rolston K. V.. 2013; Cryptococcosis due to Cryptococcus gattii. Clin Infect Dis57:552–554 [CrossRef]
    [Google Scholar]
  34. Sorrell T. C., Chen S. C.-A., Phillips P., Marr K. A.. 2011; Clinical perspectives on C. neoformansC. gattii: implications for diagnosis and management. In Cryptococcus: From Human Pathogen to Model Yeast pp595–606Edited by Heitman J., Kozel T. R., Kwon Chung K. J., Perfect J., Casadevall A.. Washington, DC: American Society for Microbiology; [CrossRef]
    [Google Scholar]
  35. Speed B., Dunt D.. 1995; Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis21:28–34 discussion 35–36. [CrossRef]
    [Google Scholar]
  36. Trilles L., Meyer W., Wanke B., Guarro J., Lazéra M.. 2012; Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol50:328–332 [CrossRef]
    [Google Scholar]
  37. Velagapudi R., Hsueh Y. P., Geunes-Boyer S., Wright J. R., Heitman J.. 2009; Spores as infectious propagules of Cryptococcus neoformans. Infect Immun77:4345–4355 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.000058
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.000058
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error